Qi Zhu Mingyun Jiang Wenfei Li Shuangli Sun Jisheng Li Justin Stebbing Xiaodong Liang Ling Peng
10.3389/fonc.2022.912426
Front Oncol
2022 May 18;12:912426.
egfr nsclc immune checkpoint inhibitor rare mutation tyrosine kinase inhibitor
CC BY
https://pubmed.ncbi.nlm.nih.gov/35664749/
Case Reports
PMC9159765
35664749
A Lung Cancer Patient Harboring a Rare Oncogenic EGFR Exon 20 V786M Mutation Responded to a Third-Generation Tyrosine Kinase Inhibitor: Case Report and Review of the Literature
2022